S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself

Waters Stock Price, News & Analysis (NYSE:WAT)

$279.74
+3.79 (+1.37%)
(As of 11/29/2023 ET)
Compare
Today's Range
$277.92
$281.98
50-Day Range
$236.70
$280.39
52-Week Range
$231.90
$353.70
Volume
302,364 shs
Average Volume
495,289 shs
Market Capitalization
$16.54 billion
P/E Ratio
25.41
Dividend Yield
N/A
Price Target
$298.00

Waters MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.89 Rating Score
Upside/​Downside
6.5% Upside
$298.00 Price Target
Short Interest
Bearish
7.26% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.56
Upright™ Environmental Score
News Sentiment
-0.14mentions of Waters in the last 14 days
Based on 46 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
3.42%
From $11.69 to $12.09 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.74 out of 5 stars

Medical Sector

796th out of 949 stocks

Analytical Instruments Industry

21st out of 28 stocks


WAT stock logo

About Waters Stock (NYSE:WAT)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

WAT Stock Price History

WAT Stock News Headlines

Proposed NewRange copper-nickel mine in Minnesota suffers fresh setback on top of years of delays
The proposed NewRange Copper Nickel mine in northeastern Minnesota has suffered a fresh setback
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
See More Headlines
Receive WAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Waters and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2023
Today
11/29/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/21/2024

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
Sector
Medical
CUSIP
94184810
Employees
8,200
Year Founded
1958

Price Target and Rating

Average Stock Price Target
$298.00
High Stock Price Target
$352.00
Low Stock Price Target
$230.00
Potential Upside/Downside
+6.7%
Consensus Rating
Reduce
Rating Score (0-4)
1.89
Research Coverage
9 Analysts

Profitability

Net Income
$707.76 million
Pretax Margin
25.84%

Debt

Sales & Book Value

Annual Sales
$2.97 billion
Cash Flow
$14.53 per share
Book Value
$15.31 per share

Miscellaneous

Free Float
58,672,000
Market Cap
$16.52 billion
Optionable
Optionable
Beta
0.90

Social Links

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Udit Batra Ph.D. (Age 52)
    President, CEO & Director
    Comp: $3.11M
  • Mr. Amol Chaubal (Age 46)
    Senior VP & CFO
    Comp: $1.23M
  • Ms. Keeley A. Aleman (Age 46)
    Senior VP, General Counsel & Corporate Secretary
    Comp: $897.33k
  • Ms. Jianqing Y. Bennett (Age 53)
    Senior Vice President of TA Instruments Division & Waters Clinical Business Unit
    Comp: $1.24M
  • Mr. Christos Ross
    Senior VP of Global Operations & Interim Senior VP of the Waters Division
  • Caspar Tudor
    Director of Investor Relations
  • Ms. Kristen Garvey
    Vice President of Corporate Communications
  • Dr. Belinda Gaye Hyde Ph.D. (Age 52)
    Senior Vice President of Global Human Resources
    Comp: $1.31M
  • Dr. Daniel Rush Ph.D.
    Senior Vice President of Strategy & Transformation
  • John Lynch
    Treasurer














WAT Stock Analysis - Frequently Asked Questions

Should I buy or sell Waters stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 1 sell rating and 8 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" WAT shares.
View WAT analyst ratings
or view top-rated stocks.

What is Waters' stock price target for 2024?

9 brokers have issued twelve-month price targets for Waters' shares. Their WAT share price targets range from $230.00 to $352.00. On average, they anticipate the company's stock price to reach $298.00 in the next twelve months. This suggests a possible upside of 6.5% from the stock's current price.
View analysts price targets for WAT
or view top-rated stocks among Wall Street analysts.

How have WAT shares performed in 2023?

Waters' stock was trading at $342.58 at the beginning of 2023. Since then, WAT shares have decreased by 18.3% and is now trading at $279.74.
View the best growth stocks for 2023 here
.

When is Waters' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 21st 2024.
View our WAT earnings forecast
.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) released its quarterly earnings data on Tuesday, November, 7th. The medical instruments supplier reported $2.84 EPS for the quarter, topping analysts' consensus estimates of $2.56 by $0.28. The medical instruments supplier had revenue of $711.69 million for the quarter, compared to analyst estimates of $722.27 million. Waters had a trailing twelve-month return on equity of 102.22% and a net margin of 21.80%. Waters's revenue was up .4% on a year-over-year basis. During the same period in the prior year, the business posted $2.64 earnings per share.
Read the conference call transcript
.

What guidance has Waters issued on next quarter's earnings?

Waters updated its fourth quarter 2023 earnings guidance on Tuesday, November, 7th. The company provided EPS guidance of $3.52-$3.62 for the period, compared to the consensus earnings per share estimate of $4.29. The company issued revenue guidance of $807.00 million-$832.75 million, compared to the consensus revenue estimate of $906.36 million.

What is Udit Batra's approval rating as Waters' CEO?

13 employees have rated Waters Chief Executive Officer Udit Batra on Glassdoor.com. Udit Batra has an approval rating of 100% among the company's employees. This puts Udit Batra in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Waters own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), RTX (RTX), CVS Health (CVS), Home Depot (HD), Johnson & Johnson (JNJ), Abbott Laboratories (ABT), Verizon Communications (VZ), Cisco Systems (CSCO) and Walmart (WMT).

Who are Waters' major shareholders?

Waters' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Bank of New York Mellon Corp (5.96%), Massachusetts Financial Services Co. MA (5.70%), Invesco Ltd. (1.85%), Impax Asset Management Group plc (1.31%), Northern Trust Corp (1.21%) and Mawer Investment Management Ltd. (1.02%). Insiders that own company stock include Christopher A Kuebler, Edward Conard, Joann A Reed, Linda Baddour, Mark P Vergnano, Michael J Berendt and Thomas P Salice.
View institutional ownership trends
.

How do I buy shares of Waters?

Shares of WAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Waters have any subsidiaries?
The following companies are subsidiares of Waters: Analytical Products Group Inc., Andrew Alliance, Andrew Alliance S.A, Andrew Alliance SA (Switzerland), Andrew Alliance SASU (France), Anter Corporation, Baehr Thermoanalyse GmbH, Blue Reference Inc., Calorimetry Sciences Corporation, ElectroForce, Environmental Resource Associates Inc. (Colorado), Environmental Resources Associates, Integrated Software Solutions, Integrated Software Solutions Limited (UK), Integrated Software Solutions USA LLC, MPE Orbur Group Ltd. (UK), Manchester International Limited (Cayman), Melbourne International Limited (Cayman), Micromass Holdings Ltd. (UK), Micromass Ltd. (UK), Micromass UK Ltd. (UK), Midland Precision Equipment Co. Ltd. (UK), Milford International Limited (Cayman), Nihon Waters K.K. (Japan), NuGenesis Technologies Corporation, Rubotherm, TA Instruments Japan Inc. (Japan), TA Instruments-Waters LLC (Delaware), Thar Instruments Inc, Thermometric AB, VICAM, VTI Corporation, Waters (TC) Israel Ltd. (Israel), Waters A/S (Denmark), Waters AG (Switzerland), Waters Analytical Instruments Sdn Bhd (Malaysia), Waters Asia Limited (Delaware), Waters Australia PTY LTD. (Australia), Waters Celtic Holdings Ltd. (Ireland), Waters China Ltd. (Hong Kong), Waters Chromatography BV (Netherlands), Waters Chromatography Europe BV (Netherlands), Waters Chromatography Ireland Ltd. (Ireland), Waters Corporation (Delaware), Waters Cromatografia SA (Spain), Waters European Investments LLC (Cayman) (2), Waters Ges.MBH (Austria), Waters Global International Limited (Cayman) (1), Waters Global Limited (UK) (1), Waters GmbH (Germany), Waters Holdings LLC (Delaware), Waters India Pvt. Ltd., Waters Kft (Hungary), Waters Korea Limited (Korea), Waters Limited (Canada), Waters Limited (UK), Waters Luxembourg SARL (Luxembourg), Waters NV (Belgium), Waters O.O.O. (Russia) (1), Waters Pacific Pte Ltd. (Singapore), Waters Research Center Kft (Hungary), Waters Romania Srl, Waters SA de CV (Mexico), Waters SAS (France), Waters Sp.Zo.o (Poland), Waters SpA (Italy), Waters Sverige AB (Sweden), Waters Tech. LC-MS Unipessol Lda (Portugal), Waters Technologies (Beijing) Co. Ltd (China), Waters Technologies (Shanghai) Ltd (China), Waters Technologies Corporation (Delaware), Waters Technologies International Limited (Cayman) (1), Waters Technologies Ireland Ltd. (Ireland), and Waters Technologies do Brasil Ltda (Brazil).
Read More
This page (NYSE:WAT) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -